- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-MPO
MPO Monoclonal Antibody for WB, IHC, IF/ICC, IF-P, FC (Intra), ELISA
Hôte / Isotype
Mouse / IgA
Réactivité testée
Humain, rat et plus (2)
Applications
WB, IHC, IF/ICC, IF-P, FC (Intra), IP, ELISA
Conjugaison
Non conjugué
CloneNo.
4C11F6
N° de cat : 66177-1-Ig
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules HL-60, |
| Résultats positifs en IHC | tissu hépatique humain, tissu d'amygdalite humain il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
| Résultats positifs en IF-P | tissu d'appendicite humain, |
| Résultats positifs en IF/ICC | cellules HL-60, |
| Résultats positifs en FC (Intra) | cellules HL-60, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:8000 |
| Immunohistochimie (IHC) | IHC : 1:400-1:1600 |
| Immunofluorescence (IF)-P | IF-P : 1:200-1:800 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 1 publications below |
| WB | See 13 publications below |
| IHC | See 18 publications below |
| IF | See 40 publications below |
| IP | See 1 publications below |
| ELISA | See 1 publications below |
Informations sur le produit
66177-1-Ig cible MPO dans les applications de WB, IHC, IF/ICC, IF-P, FC (Intra), IP, ELISA et montre une réactivité avec des échantillons Humain, rat
| Réactivité | Humain, rat |
| Réactivité citée | rat, bovin, Humain, Vache |
| Hôte / Isotype | Mouse / IgA |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | MPO Protéine recombinante Ag17564 |
| Nom complet | myeloperoxidase |
| Masse moléculaire calculée | 745 aa, 84 kDa |
| Poids moléculaire observé | 90 kDa |
| Numéro d’acquisition GenBank | BC130476 |
| Symbole du gène | MPO |
| Identification du gène (NCBI) | 4353 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Précipitation de l'acide caprylique/du sulfate d'ammonium |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
The MPO gene encodes myeloperoxidase, a lysosomal hemoprotein located in the azurophilic granules of polymorphonuclear (PMN) leukocytes and monocytes. In response to stimulation, MPO is activated into a transient intermediate with potent antimicrobial oxidizing abilities(PMID:17650507). The mRNA is translated into a single protein of 90 kDa, which displays enzymatic activity and undergoes proteolytic maturation into a heavy chain of 59 kDa and a light chain of 13.5 kDa; these subunits then dimerize into the mature tetramer and the mature MPO is a heterotetramer composed of two identical heavy chains and two identical light chains(PMID:12773517). Fragments with molecular masses of 43-47 kDa were formed by autocatalysis during warming in sample buffer (PMID:12960244). The 24-kDa material had a map identical to that of 13.5 kDa subunit and represents a dimer of the 13.5 kDa subunit (PMID:3008892). Defects in MPO are the cause of myeloperoxidase deficiency (MPOD). It has 3 isoforms produced by alternative splicing.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for MPO antibody 66177-1-Ig | Download protocol |
| IHC protocol for MPO antibody 66177-1-Ig | Download protocol |
| IF protocol for MPO antibody 66177-1-Ig | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Nat Commun Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma | ||
Cell Death Differ NLRX1 mediated impaired microglial phagocytosis of NETs in cerebral ischemia and reperfusion injury | ||
PLoS Pathog Prion protein signaling induces M2 macrophage polarization and protects from lethal influenza infection in mice. | ||
Int Immunopharmacol Sappanone A enhances hepatocyte proliferation in lipopolysaccharide-induced acute liver injury in mice by promoting injured hepatocyte apoptosis and regulating macrophage polarization | ||
FEBS J A combined model of serum neutrophil extracellular traps, CD8+ T cells, and tumor proportion score provides better prediction of PD-1 inhibitor efficacy in patients with NSCLC | ||
Sci Rep Persisting and Increasing Neutrophil Infiltration Associates with Gastric Carcinogenesis and E-cadherin Downregulation. |








